FDA Grants Emergency Use Authorization for Pfizer's COVID-19 Boosters for Kids 5-11
The decision now falls to the CDC
U.S. officials have authorized a booster of Pfizer's COVID-19 vaccine for children aged 5-11 under an emergency use authorization.
The U.S Food and Drug Administration (FDA) announced the update Tuesday, a win celebrated vaccine advocates seeking to protect the nation's youngest. The decision now falls to the Centers for Disease Control and Prevention (CDC) on whether to formally recommend the vaccine for that age group.
The CDC's scientific advisers are scheduled to meet on Thursday.
Please select this link to read the complete article from WBNS-10TV.